Vireo Growth (VREOF) Change in Inventory (2020 - 2026)
Vireo Growth (VREOF) posted Change in Inventory of $2.2 million for Q1 2026, down 65.12% sequentially from $6.3 million in Q4 2025, and up 10.0% YoY from $2.0 million in Q1 2025.
Vireo Growth (VREOF) Change in Inventory (2020 - 2026) Analysis & Trends
Vireo Growth has reported Change in Inventory for 7 years, with the latest figure at $2.2 million in Q1 2026.
- Quarterly Change in Inventory rose 10.0% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (up 89.83% YoY) and the FY2025 annual result came in at $8.7 million, up 263.95% from the prior year.
- Change in Inventory eased to $2.2 million in Q1 2026 per VREOF's latest filing, from $6.3 million in the prior quarter.
- Over five years, Change in Inventory peaked at $6.3 million in Q4 2025 and troughed at -$3.3 million in Q2 2025.
- A 5-year average of $1.1 million and a median of $706986.0 in 2024 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 4833.61% in 2025, down 563.48% in 2025.
- Over 5 years, Change in Inventory stood at $1.8 million in 2022, then plunged by 106.11% to -$109163.0 in 2023, then jumped by 1849.33% to $1.9 million in 2024, then soared by 230.34% to $6.3 million in 2025, then tumbled by 65.12% to $2.2 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $2.2 million, $6.3 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 6.31 Mn |
| Dec 31, 2025 | 6.31 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 74,458.00 |
| Sep 30, 2024 | 74,458.00 |
| Jun 30, 2024 | 706,986.00 |
| Jun 30, 2024 | 706,986.00 |
| Mar 31, 2024 | -299,252.00 |
| Mar 31, 2024 | -299,252.00 |
| Dec 31, 2023 | -109,163.00 |
| Dec 31, 2023 | -109,163.00 |